Drug intelligence / Profile preview

microcrystalline cellulose + methylcellulose

Development stage
Unknown
Lead developer
Rachel Holden
Modality
Small Molecules
Administration
Oral
01

Overview

Microcrystalline cellulose and methylcellulose are pharmaceutical excipients used in combination as a placebo in the iPACK-HD (Inhibit Progression of Coronary Artery Calcification With Vitamin K in HemoDialysis Patients) study. Led by Dr. Rachel Holden at Queen's University, this Phase 2 clinical trial evaluated the efficacy of high-dose vitamin K1 (phylloquinone) in reducing the progression of coronary artery calcification in patients receiving hemodialysis. The microcrystalline methylcellulose formulation was designed to be identical in appearance to the 10mg vitamin K1 tablets and was administered orally three times weekly over a 12-month period to the control group. As a placebo, the substance is intended to be biologically inert and does not possess a therapeutic mechanism of action for cardiovascular or renal diseases.

Other names
Microcrystalline Methylcellulose

Beyond the preview

Go deeper on microcrystalline cellulose + methylcellulose.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on microcrystalline cellulose + methylcellulose.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call